Your browser doesn't support javascript.
loading
Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma.
Chen, Lindi; Pastorino, Fabio; Berry, Philip; Bonner, Jennifer; Kirk, Calum; Wood, Katrina M; Thomas, Huw D; Zhao, Yan; Daga, Antonio; Veal, Gareth J; Lunec, John; Newell, David R; Ponzoni, Mirco; Tweddle, Deborah A.
Afiliação
  • Chen L; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Pastorino F; Laboratory of Experimental Therapy in Oncology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Berry P; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Bonner J; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Kirk C; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Wood KM; Department of Cellular Pathology, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
  • Thomas HD; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Zhao Y; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Daga A; Oncologia Cellulare, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Veal GJ; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Lunec J; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Newell DR; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Ponzoni M; Laboratory of Experimental Therapy in Oncology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Tweddle DA; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
Int J Cancer ; 144(12): 3146-3159, 2019 06 15.
Article em En | MEDLINE | ID: mdl-30536898
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirrolidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas c-mdm2 / Para-Aminobenzoatos / Temozolomida / Neuroblastoma Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirrolidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas c-mdm2 / Para-Aminobenzoatos / Temozolomida / Neuroblastoma Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido